Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Combined Effects of Neurodynamics With PNF on Pain and ROM in Patients With CTS.

4. maj 2026 opdateret af: Riphah International University

Combined Effects of Neurodynamics With Proprioceptive Neuromuscular Facilitation Technique on Pain and Range of Motion in Patient With Carpal Tunnel Syndrome.

The goal of this clinical trial is to determine the combined effects of neurodynamics with proprioceptive neuromuscular facilitation technique on reducing pain and improving range of motion in patients with carpal tunnel syndrome. This study evaluates whether neurodynamics combined with PNF is an effective approach in treating CTS compared to baseline treatment, as both techniques are well known for their individual effects. This treatment is given for 2 weeks, 5 days per week with 10 repetitions for each exercise.

Studieoversigt

Status

Afsluttet

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

48

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Punjab Province
      • Chak Four Hundred Fifty-four, Punjab Province, Pakistan, 63100
        • Bahawal Victoria Hospital

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen

Tager imod sunde frivillige

Ingen

Beskrivelse

Inclusion Criteria:

  • Diagnosed cases of carpal tunnel syndrome.
  • Patients having positive Tinel's test and Phalen's test.
  • Symptoms persisted for at least 4 weeks.
  • Availability and motivation of patients to participate in a 2-week program.

Exclusion Criteria:

  • Patient with contraindications to rehabilitation treatment.
  • Patients with a history of previous upper limb surgery.
  • Patient received steroid injection or have any systemic disease that can influence condition.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Neurodynamic with PNF
PNF technique include Rhythmic Initiation along with agonistic reversals. Neurodynamics includes the distal nerve tension technique along with nerve sliding.

These 2 exercises were provided in 10 repetitions for 2 weeks (duration), 5 days per week (frequency).

i) PNF techniques used in carpal tunnel treatment includes

  1. Rhythmic Initiation
  2. Agonistic Reversals. ii) For Neurodynamic

(1) Distal nerve tension technique :Hand was placed in six different positions each position maintained for 7 second and have 5 repetitions for each step this is done in median nerve tension technique (2) nerve slide

Andre navne:
  • Neurodynamisk
  • Proprioceptive Neuromuscular Facilitation technique
Aktiv komparator: Baseline treatment
Wrist splint along with ultrasound therapy, cold therapy, and medication like NSAIDs.

They were provided with common conservative physical therapy treatment for 2 weeks, 5 days per week, following carpal tunnel syndrome.

These treatments included use of a wrist splint, especially at night, along with 10-15 min of cold and ultrasound therapy. Medications like NSAIDs were given for 5 days.

Andre navne:
  • Ultralydsbehandling
  • medicin
  • Forkølelsesterapi
  • håndledsskinne

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Quick DASH Questionnaire
Tidsramme: 2nd week

Changes from Baseline Quick DASH questionnaire (Quick Disabilities of the Arm, Shoulder, and Hand) is a concise version of the DASH questionnaire. It consists of 11 items, with each item scored from 1 (no difficulty) to 5 (unable to perform), assessing daily activities, pain, and social functioning, along with optional modules for work or sports/performing arts. The total score ranges from 0 to 100, where 0 indicates no disability and 100 indicates the most severe disability.

Score Ranges:

0-20: Minimal disability 21-40: Mild to moderate disability 41-60: Moderate to severe disability 61-100: Extreme disability The score is calculated by summing responses, dividing by the number of items (n), subtracting 1, and multiplying by 25.

2nd week
Visual Analog Scale
Tidsramme: 2nd week
The Visual Analog Scale (VAS) is a frequently utilized tool in clinical and research settings to measure subjective experiences like pain. It was first developed in 1921 by psychologists Mary H.S. Hayes and Donald G. Paterson as a "graphic rating" method for subjective assessments, later adopted and adapted for measuring pain and clinical symptoms in the 1960s. It consists of a 10 cm line where patients spot their pain intensity, from 0 "no pain" at one end to 10 "unbearable pain" at the other.
2nd week

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Arnab Altaf, ppdpt, Riphah International University

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

1. januar 2025

Primær færdiggørelse (Faktiske)

1. oktober 2025

Studieafslutning (Faktiske)

1. oktober 2025

Datoer for studieregistrering

Først indsendt

27. marts 2026

Først indsendt, der opfyldte QC-kriterier

4. maj 2026

Først opslået (Faktiske)

7. maj 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

7. maj 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

4. maj 2026

Sidst verificeret

1. maj 2026

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner